{
  "completed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9
  ],
  "results": [
    {
      "example_idx": 0,
      "dataset_id": "1511",
      "question": "What is a lockdown?",
      "ground_truth_answer": "A lockdown is the implementation of strict restrictions and measures to limit people's movement and activities in order to control the spread of infections, such as the one mentioned in the given context.",
      "generated_response": "<think>\nOkay, the user is asking, \"What is a lockdown?\" and the context provided has multiple entries with the title \"Estimating the number of infections and the impact of non-\" followed by \"Passage: Lockdown\" and one entry with \"banned Implemented with lockdown.57 24/3/2020\". \n\nFirst, I need to figure out what the context is. The titles mention estimating infections and the impact of non-... but the passage just says \"Lockdown\" each time. The last entry has \"banned Implemented with lockdown.57 24/3/2020\". Maybe that's a typo or part of a larger text. The date 24/3/2020 is March 24, 2020, which is around when many countries started lockdowns due to the pandemic.\n\nSince the context is limited, I need to rely on general knowledge. A lockdown is a public health measure where people are required to stay at home to prevent the spread of a disease, like COVID-19. It involves restrictions on movement, closing non-essential businesses, schools, and limiting gatherings. The context mentions \"non-\" which might be part of \"non-pharmaceutical interventions\" (NPIs), which include lockdowns. The number 57 could refer to a study or a statistic, but without more info, it's hard to say. \n\nThe user probably wants a concise definition based on the context. Since the context is about estimating infections and lockdowns, the answer should connect lockdowns to controlling infection spread. I should mention that it's a restrictive measure to limit movement and gatherings to reduce transmission. Also, note that the context might be discussing the impact of not implementing lockdowns, hence \"non-\" in the title. The date might indicate when a lockdown was implemented. \n\nI need to make sure the answer is accurate but doesn't include guesses. Since the context is minimal, the answer should be based on common knowledge but tied to the given context. So, the answer should define a lockdown as a public health measure to restrict movement and gatherings to control disease spread, possibly referencing the context's focus on infection estimation and lockdown implementation dates.\n</think>\n\nA **lockdown** is a public health measure implemented to restrict movement and gatherings of people in order to slow the spread of infectious diseases, such as during the COVID-19 pandemic. It typically",
      "retrieved_chunks": [
        "Title: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: banned Implemented with lockdown.57 24/3/2020"
      ],
      "computed_relevance": 1.0,
      "computed_utilization": 1.0,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.2,
      "gt_utilization": 0.2,
      "gt_completeness": 1.0,
      "gt_adherence": 0.0,
      "binary_pred": 0,
      "binary_gt": 0,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 1,
      "dataset_id": "1085",
      "question": "What complications are associated with CHIKV?",
      "ground_truth_answer": "Complications associated with CHIKV include respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure.",
      "generated_response": "<think>\nOkay, let's see. The user is asking about complications associated with CHIKV, which I know stands for Chikungunya virus. The context provided mentions that mothers can transmit it to their babies during the perinatal period, and that it's linked to high morbidity. By day 4 of life, all neonates showed symptoms similar to CHIKF (Chikungunya fever). Six of them got confirmed with CHIKV and developed meningoencephalitis.\n\nSo, the main complications here are the transmission from mother to child, leading to severe symptoms in newborns. The key points from the context are the perinatal transmission, high morbidity, and the development of meningoencephalitis in some cases. The answer should include these elements. Also, since the title mentions it's a potentially emerging epidemic, maybe that's a hint to mention the broader implications, but the question is specifically about complications. I need to make sure I don't add extra info not in the context. Let me check again: the complications are high morbidity, symptoms in neonates by day 4, and meningoencephalitis in six cases. So the answer should list those.\n</think>\n\nThe complications associated with CHIKV (Chikungunya virus) include **perinatal transmission from mothers to neonates**, leading to severe symptoms in newborns. By day 4 of life, all infected neonates exhibited symptoms resembling Chikungunya fever (CHIKF), and six confirmed cases developed **meningoencephalitis**, a severe inflammation of the brain and meninges. Additionally, the transmission is linked to a **high degree of morbidity**, indicating significant illness severity in affected individuals.",
      "retrieved_chunks": [
        "discovered that mothers could transmit CHIKV to their progeny during the perinatal period , and it is associated with a high degree of morbidity. By mean Day 4 of life, all of the neonates were symptomatic for CHIKV, exhibiting common CHIKF symptoms. Six neonates were confirmed to have contracted CHIKV and developed mengoencephalitis.",
        "Title: Chikungunya: A Potentially Emerging Epidemic?",
        "Title: Chikungunya: A Potentially Emerging Epidemic?",
        "Title: Chikungunya: A Potentially Emerging Epidemic?",
        "Title: Chikungunya: A Potentially Emerging Epidemic?"
      ],
      "computed_relevance": 0.42857142857142855,
      "computed_utilization": 0.42857142857142855,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.2,
      "gt_utilization": 0.2,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 2,
      "dataset_id": "1248",
      "question": "What does Clade A contain?",
      "ground_truth_answer": "Clade A contains 1,889 viruses from 34 countries collected from 2010 to the present.",
      "generated_response": "<think>\nOkay, let's see. The user is asking, \"What does Clade A contain?\" based on the provided context. Let me look through the passages given.\n\nFirst, the context mentions a paper titled \"A Phylogeny-Based Global Nomenclature System...\" focusing on H1 Hemagglutinin genes from swine influenza A viruses. The passages talk about different clades like 1A, 1B, 1C.2, etc. \n\nLooking at the first passage: It says the 1A lineage has 1,889 viruses from 34 countries collected from 2010 to present. They refined 1A into three second-order divisions. There's a mention of 1C.2 as an exception in the 1A lineage. Wait, no, the first passage says \"The one within-clade exception in this lineage was 1C.2...\" but the lineage being discussed here is 1A. Wait, that seems odd. Maybe a typo? Or perhaps 1C.2 is part of 1A? The passage says \"The one within-clade exception in this lineage was 1C.2...\" but the lineage is 1A. So maybe 1C.2 is a subclade under 1A? But the title of the first passage is about 1A swine lineage. \n\nThen the second passage talks about 1B human seasonal lineage and mentions exceptions in between-clade thresholds. The third passage discusses seven clades, with 1B.1 and 1B.2 as within-clade exceptions. Also mentions 1C Eurasian avian lineage in Europe and Asia.\n\nBut the question is about Clade A. However, in the provided passages, the clades mentioned are 1A, 1B, 1C.2, 1B.1, 1B.2, 1B.1.1, and 1C. The user is asking about Clade A, but the context refers to 1A, 1B, etc. So maybe there's a confusion between Clade A and 1A? The user might have meant 1A. Let me check again.\n\nThe first passage starts with \"Clade designations for 1A swine lineage.\" So 1A is a clade. The question is about Clade A. But in the context",
      "retrieved_chunks": [
        "Title: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: Clade designations for 1A swine lineage. The 1A lineage contained 1,889 viruses from 34 countries collected from 2010 to the present . According to our nomenclature rules, we refined the classification of 1A viruses into three second-order divisions, each of which corresponds to earlier, regional classifica- Table 2 .",
        "The one within-clade exception in this lineage was 1C.2 , which had multiple monophyletic\n\nTitle: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: The 1B human seasonal lineage within-and between-clade APDs are presented in Table 3 .",
        "The exception to the between-clade threshold was associated with clades\n\nTitle: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: were placed into seven clades. The numerically dominant clades reflected intensive surveillance in the United States , investigator sequencing efforts in Canada , and the rapid dissemination of the 2009 H1N1 pandemic virus across global swine populations .",
        "For the most part, each clade had an APD of \u03fe7% from other clades and almost all had an APD of \u03fd7% within the clade. The within-clade exceptions were the 1B.1 and 1B.2 clades . The 1B.1 second-order clade had too few representative sequences to calculate genetic distance, and 1B.2 represented multiple monophyletic clades that individually did not meet our criteria for further division. Similarly, the extensive 1B.1.1 clade did not meet criteria for further splitting.",
        "Similarly, coordinated surveillance in Europe and Asia captured two primary clades of 1C Eurasian avian lineage currently circulating in the two continents."
      ],
      "computed_relevance": 0.18181818181818182,
      "computed_utilization": 0.18181818181818182,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 1.0,
      "gt_utilization": 0.041666666666666664,
      "gt_completeness": 0.041666666666666664,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 3,
      "dataset_id": "1696",
      "question": "How do the S1 subunits compare with that of SARS-likeCOV and human SARS-COV?",
      "ground_truth_answer": "The S1 subunit of 2019-nCoV shares around 70% identity with those of two bat SARS-like CoVs and human SARS-CoV.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how the S1 subunits of 2019-nCoV compare to those of SARS-like CoVs and human SARS-CoV. \n\nFirst, I need to look at the provided context. The passage mentions that the S1 subunit of 2019-nCoV shares around 70% identity with the two bat SARS-like CoVs and human SARS-CoV. The S2 subunit is more conserved at 99% identity. Also, there's a note about the core domain of the RBD (receptor binding domain) being highly conserved.\n\nSo, the key points here are the percentage identity for the S1 subunit. The answer should state that the S1 subunit of 2019-nCoV has about 70% identity with the SARS-like CoVs and human SARS-CoV. Additionally, the core RBD domain is conserved. The S2 subunit is more conserved, but the question is specifically about S1.\n\nI need to make sure I don't mix up S1 and S2. The user is only asking about S1. Also, the context mentions that most bat SARSr-CoVs have deletions in the spike RBD compared to human SARS-CoV, but the 2019-nCoV's core RBD is conserved. So maybe that's an important point to include as well, even though the question is about the S1 subunit. The RBD is part of the S1 subunit, right? Because the spike protein is divided into S1 and S2. The S1 subunit contains the RBD, which is crucial for binding to the host receptor. So the core domain of RBD being conserved despite lower overall identity in S1 might be a key point.\n\nPutting it all together: The S1 subunit of 2019-nCoV shares about 70% identity with SARS-like CoVs and human SARS-CoV. However, the core RBD domain is highly conserved. This suggests that while the overall S1 subunit is less similar, the critical receptor-binding part is preserved. The answer should reflect both the 70% identity and the conserved RBD core.\n</think>\n\nThe S1 subunit of 2019-nCoV",
      "retrieved_chunks": [
        "Unlike 2019-nCoV and human SARS-CoV, most known bat SARSr-CoVs have two stretches of deletions in the spike receptor binding domain when compared with that of human SARS-CoV.",
        "We found that the S2 subunit of 2019-nCoV is highly conserved and shares 99% identity with those of the two bat SARS-like CoVs and human SARS-CoV .",
        "Though the S1\n\nTitle: Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan\nPassage: subunit of 2019-nCoV shares around 70% identity to that of the two bat SARS-like CoVs and human SARS-CoV ), the core domain of RBD are highly conserved ).",
        "The 2019-nCoV had the same SL6, SL7, and SL8 as SARS-CoV, and an additional",
        "Learning from the roles of civet in SARS and camel in MERS, hunting for the animal source of 2019-nCoV and its more ancestral virus would be important for understanding the origin and evolution of this novel lineage B betacoronavirus."
      ],
      "computed_relevance": 0.2,
      "computed_utilization": 0.4,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.12,
      "gt_utilization": 0.04,
      "gt_completeness": 0.3333333333333333,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 4,
      "dataset_id": "669",
      "question": "What is Bacillus subtilis?",
      "ground_truth_answer": "Bacillus subtilis is a species of bacteria that has been shown to be effective in the prevention and/or treatment of intestinal diseases such as diarrhea, colitis, irritable bowel syndrome, irritable bowel disease, and colorectal cancer. It is also a part of the normal intestinal microbiome and has been found in the healthy human gastrointestinal tract. Bacillus subtilis produces surfactins, fengycins, and iturins, which have antimicrobial and antiviral properties.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking, \"What is Bacillus subtilis?\" and they provided some context. First, I need to parse the context to extract relevant information.\n\nLooking at the context, it mentions that Bacillus spp., specifically subtilis, helps restore balance in gut microflora. It increases beneficial species like Bifidobacterium, Lactobacillus, and Butyricicoccus, while reducing harmful ones like Acinetobacter, Ruminococcus, Clostridium, and Veillonella. The title of the passage is \"Secretome of Intestinal Bacilli: A Natural Guard against Pathologies,\" which suggests that Bacillus species, including subtilis, play a protective role in the gut.\n\nThe passage also states that Bacillus species are found in the healthy human gastrointestinal tract (GIT) and are more colonizing than transient. Additionally, it mentions that in the environment, their vegetative forms are near decomposing plants. Sporulation is noted, which is a survival mechanism for Bacillus species.\n\nPutting this together, Bacillus subtilis is a species of Bacillus that's beneficial in the gut. It helps maintain a healthy microbiome by promoting good bacteria and inhibiting harmful ones. It's part of the natural defense against gut pathologies. The fact that it's found in the GIT and can form spores is important for its survival and function.\n\nI should make sure not to include information not in the context. For example, the context doesn't mention specific mechanisms like enzymes or compounds produced by B. subtilis, so I shouldn't assume those. Just stick to what's given: role in gut flora balance, presence in GIT, sporulation, and environmental presence near decomposing plants.\n\nSo the answer should define Bacillus subtilis as a beneficial bacterium in the gut that restores microbial balance by increasing good bacteria and reducing harmful ones. Mention its presence in the human GIT, sporulation, and environmental habitat. Avoid adding extra details not provided.\n</think>\n\nBacillus subtilis is a species of the *Bacillus* genus that plays a beneficial role in maintaining gut health. It helps restore balance in the intestinal microbiota by promoting the growth of beneficial bacteria such as *Bifidobacterium*, *Lactobacillus*, and *Butyricicoccus* spp., while reducing harmful species like *Acinetob",
      "retrieved_chunks": [
        "Bacillus spp.",
        "subtilis restored balance in gut microflora: beneficial species of Bifidobacterium, Lactobacillus, and Butyricicoccus spp. were increased, while gut damage-promoting species of Acinetobacter sp., Ruminococcus sp., Clostridium spp., and Veillonella sp.",
        "Sporulation of B.",
        "In environment, the vegetative forms of Bacillus are present usually near decomposing plants and in their\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: B.",
        "have been isolated from the healthy human GIT, where they are well-adapted and are more colonizing than transient ."
      ],
      "computed_relevance": 0.3333333333333333,
      "computed_utilization": 0.5,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.4090909090909091,
      "gt_utilization": 0.18181818181818182,
      "gt_completeness": 0.3333333333333333,
      "gt_adherence": 0.0,
      "binary_pred": 0,
      "binary_gt": 0,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 5,
      "dataset_id": "81",
      "question": "What past research has been done on severe, single-wave pandemics?",
      "ground_truth_answer": "The given passages do not specifically mention past research on severe, single-wave pandemics. However, they do reference research on pandemic strains, influenza spread, and pandemic severity categories, as well as the origins and circulation of specific pandemic influenza strains.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about past research on severe, single-wave pandemics. I need to look through the provided contexts to find relevant information.\n\nFirst, looking at the first context about the 1889 pandemic. It mentions three major waves from 1889 to 1892, with the 1892 wave being the most intense. The passage also speculates about herald waves of the 1918 pandemic possibly starting as early as 1915. However, the 1889 pandemic itself had multiple waves, so that's not a single-wave example. But maybe the 1918 pandemic is mentioned here? Wait, the 1918 pandemic is known for having multiple waves, so that's not helpful here.\n\nNext, the second context is about the 2009 H1N1 pandemic in Hong Kong. It talks about using convalescent plasma and a small study showing its effectiveness. The passage also mentions that there were models compared, but it's not clear if the pandemic in question here was a single wave. The 2009 pandemic did have multiple waves in some regions, but maybe in Hong Kong it was a single wave? The passage doesn't specify the number of waves, so I can't confirm that from this context.\n\nThird context is about Taiwan's study on the 2009 pH1N1 pandemic. They used a Richards model variation to analyze multiple waves. The passage mentions two types of turning points in multi-wave epidemics. So this is about multi-wave, not single-wave. Not helpful here.\n\nFourth context discusses economic analysis of mitigation strategies for pandemics with five severity categories, referencing studies on the 2009 pandemic. The 2009 pandemic is mentioned again, but again, it's not clear if it was a single wave. The 2009 H1N1 pandemic is generally considered to have had multiple waves globally, though some regions might have experienced it as a single wave. The context here doesn't specify, but the study in question is about different severity categories and interventions, not the number of waves.\n\nWait, the user is asking about severe, single-wave pandemics. The contexts provided don't directly mention any single-wave pandemics. The 1889 example had three waves, 1918 had multiple, 2",
      "retrieved_chunks": [
        "Title: The origins of the great pandemic\nPassage: Because the 1889 pandemic unfolded with three major waves worldwide from 1889 to 1892 , with the 1892 wave being the most intense, at least on the East Coast of the USA, it seems worth considering whether so-called herald waves of the 1918 pandemic might have stretched back all the way to 1915. Viruses with identical or nearly identical genome sequences to those in the fall wave were circulating in early 1918 , at a time prior to the recognition of a new pandemic. It is perhaps not so great a leap to imagine that these viruses were related to\n\nTitle: The epidemiological and public health research response to 2009 pandemic influenza A(H1N1): experiences from Hong Kong\nPassage: of convalescent plasma to treat severe infections was shown to be feasible in a pandemic 57 and evidence of its effectiveness albeit from a small study should justify further studies.",
        "Also in contrast with those models,\n\nTitle: On Temporal Patterns and Circulation of Influenza Virus Strains in Taiwan, 2008-2014: Implications of 2009 pH1N1 Pandemic\nPassage: When there is more than one wave of infections, as in our current study, a variation of the Richards model can be utilized, which makes the distinction between two types of turning points ; one type which occurs at the peak incidence, and a second type which occurs in a multi-wave epidemic when the growth rate of the cumulative case number begins to increase again, indicating the beginning of the next wave.",
        "To give two specific examples, local researchers confirmed the origins of the 2009 pandemic strain by comparison with a detailed local swine influenza surveillance program, 65 and performed important basic studies on pathogenesis. 66 Two sets of studies\n\nTitle: Economic analysis of pandemic influenza mitigation strategies for five pandemic severity categories\nPassage: Several related studies which also used individualbased simulation models of influenza spread coupled with costing models are those of those of Sander et al., Perlroth et al., Brown et al., and Andradottir et al.",
        "56 While we focused on research into the epidemiology, impact, and control of pH1N1, much important research on pH1N1 has been carried out in other areas outside the scope of our review.",
        "The current study extends upon the scope of these studies in several ways: five gradations of pandemic severity are considered, more combinations of interventions are considered, social distancing interventions of varying durations are considered, and probabilities of severe health outcomes for each severity category are based on fatality, hospitalization and ICU usage data as observed from the 2009 pandemic."
      ],
      "computed_relevance": 0.0,
      "computed_utilization": 0.875,
      "computed_completeness": 0.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.26666666666666666,
      "gt_utilization": 0.26666666666666666,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 6,
      "dataset_id": "1564",
      "question": "How many reported viral pneumonia?",
      "ground_truth_answer": "The passage does not provide a specific number of reported viral pneumonia cases overall. However, it mentions 2744 confirmed cases of pneumonia with 2019-nCoV infection in China, and it also mentions 77 fatal cases of pandemic H1N1v 2009 infection.",
      "generated_response": "<think>\nOkay, let's see. The user is asking how many reported viral pneumonia cases there are based on the provided context. Let me go through each passage to find relevant numbers.\n\nFirst, the first passage talks about patients with pneumonia being more likely to receive antiviral therapy. But it doesn't mention specific numbers of cases. The second passage mentions 77 fatal cases of H1N1 with 29% having bacterial co-infection. But that's about co-infection, not the total viral pneumonia cases.\n\nThe third passage discusses attack rates in different age groups during the 2009 H1N1 pandemic. It gives percentages but no exact numbers. The fourth passage is about 2019-nCoV (COVID-19) and states 2744 confirmed cases of pneumonia with the virus as of January 26, 2020. That seems like a direct number. \n\nWait, the question is about \"reported viral pneumonia.\" The fourth passage specifically mentions 2744 confirmed cases of pneumonia with 2019-nCoV infection. The other passages don't give exact numbers. The first three are about influenza-related pneumonia but don't specify total numbers. The fourth is the only one with a concrete number. So the answer should be 2744. Let me double-check if there are other numbers. The first passage mentions \"confirmed cases reported from Hong Kong, Macao and Taiwan of China,\" but the number isn't filled in. The sentence is cut off. So that's incomplete. The fourth passage's number is complete. Therefore, the answer is 2744.\n</think>\n\nThe provided context includes a passage stating that as of January 26, 2020, the National Health Commission of China recorded **2,744 confirmed cases of pneumonia with 2019-nCoV (COVID-19) infection**. This is the only specific number directly reporting viral pneumonia cases in the context. Other passages discuss influenza-related pneumonia but do not provide exact case counts. \n\n**Answer:** 2,744.",
      "retrieved_chunks": [
        "Title: Pneumonia among adults hospitalized with laboratory-confirmed seasonal influenza virus infection\u2014United States, 2005\u20132008\nPassage: Patients with pneumonia ] were significantly more likely to receive influenza antiviral therapy than patients without pneumonia ; P <0.01].",
        "A total of confirmed cases were reported from Hong Kong, Macao and Taiwan of China:\n\nTitle: Clinical review: Primary influenza viral pneumonia\nPassage: Bacterial co-infection, though uncommonly reported in the early stages of the 2009 H1N1 pandemic, may be more prevalent than initially thought. A recent analysis of lung specimens from 77 fatal cases of pandemic H1N1v 2009 infection found a prevalence of concurrent bacterial pneumonia in 29% of these patients .",
        "Title: Clinical review: Primary influenza viral pneumonia\nPassage: age versus 6% to 9% of the adults 18 to 64 years of age and none of the children . Influenza attack rates during seasonal epidemics vary between 10% and 20% but can be much higher during pandemics. For example, an analysis of the pandemic 2009 H1N1 influenza A outbreak in La Gloria, Veracruz, found clinical attack rates of 29% in adults older than 15 years and 61% in children younger than 15 years of age .",
        "Title: A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)\nPassage: At 24:00 on 26 January 2020, the National Health Commission of the People's Republic of China has recorded a total of 2744 confirmed cases of pneumonia with 2019-nCoV infection from 30 provinces , including 461 severe cases and 80 deaths.",
        "The most common coinfecting bacterial pathogens were pneumococcus, Staphylococcus aureus, and Streptococcus pyogenes, with a median duration of illness of 6 days ."
      ],
      "computed_relevance": 0.125,
      "computed_utilization": 0.5,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.125,
      "gt_utilization": 0.125,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 7,
      "dataset_id": "1247",
      "question": "How has most of the analysis of MERS-CoV genetics  been performed?",
      "ground_truth_answer": "Most of the analysis of MERS-CoV genetics has been performed using high throughput or \"deep\" sequencing methods for complete genome deduction.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how most of the analysis of MERS-CoV genetics has been performed. I need to look through the provided context to find the answer.\n\nLooking at the first passage, it starts with \"Most of the analysis of MERS-CoV genetics has been performed using high throughput or 'deep' sequencing methods for complete genome deduction.\" That seems like the direct answer. The key terms here are \"high throughput\" and \"deep sequencing methods.\" \n\nI should check the other passages to make sure there's no conflicting information. The second passage mentions genetic recombination studies but doesn't talk about the methods used. The third passage discusses genome analyses and specific regions like the spike protein, but again, the method isn't mentioned there. The fourth passage talks about genetic makeup and lineages swapping material but doesn't specify the analysis method. \n\nSo the first passage clearly states that high throughput or deep sequencing is the primary method. The answer should be that most analysis has been done using high throughput or deep sequencing methods for complete genome deduction. I need to present this answer concisely, making sure to include the key terms from the passage.\n</think>\n\nMost of the analysis of MERS-CoV genetics has been performed using **high throughput or \"deep\" sequencing methods for complete genome deduction**. This approach was highlighted as the first widespread use of deep sequencing to study an emerging viral outbreak with global reach.",
      "retrieved_chunks": [
        "Title: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Most of the analysis of MERS-CoV genetics has been performed using high throughput or \"deep\" sequencing methods for complete genome deduction . MERS-CoV was the first subject of such widespread use of deep sequencing to study an emerging viral outbreak with global reach.",
        "Whole genome sequencing has been used extensively to study MERS-CoV travel and variation and although it remains a tool for experts, it appears\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Two studies during 2015, one looking at Jeddah-2014 MERS-CoV variants and another looking at a variant exported from South Korea to China, have now identified signs of genetic recombination among MERS-CoV variants.",
        "Despite assays having been published early on, subgenomic sequencing, once the mainstay of viral outbreak studies, has less often been published during MERS-CoV\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Analyses of MERS-CoV genomes have shown that most single nucleotide differences among variants were located in the last third of the genome , which encodes the spike protein and accessory proteins . At least nine MERS-CoV genomes contained amino acid substitutions in the receptor binding domain of the spike protein and codons 158 , 460 , 1020 , 1202 and 1208 bear investigation as markers of adaptive change . The spike protein had not changed in the recombinant MERS-CoV genome identified in China in 2015 but was reported to have varied at a higher rate than that for complete MERS-CoV\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Vigilance remains important for containment since MERS-CoV is a virus with a genetic makeup that has been observed for only three years and is not stable.",
        "While human and camel whole genome sequences have retained >99 % identity with each other, members of genetically distinct lineages can and do swap genetic material when suitable conditions and coinfections co-occur .",
        "The technique can produce genomic ."
      ],
      "computed_relevance": 0.125,
      "computed_utilization": 0.5,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.2857142857142857,
      "gt_utilization": 0.047619047619047616,
      "gt_completeness": 0.16666666666666666,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 8,
      "dataset_id": "1129",
      "question": "How were  the spread of GFP-expressing virus-infected cells tracked?",
      "ground_truth_answer": "The spread of GFP-expressing virus-infected cells was tracked using immunofluorescence microscopy, whole-organ imaging with IVIS, flow cytometry, and inverted fluorescence microscopy.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how the spread of GFP-expressing virus-infected cells was tracked. Let me look through the provided context and passages to find the relevant information.\n\nFirst, the context mentions that images show GFP-expressing cells in white and non-GFP in black. The authors used a 10^6 PFU intranasal inoculation and observed percentages of GFP+ cells at 48 hours. \n\nLooking at the first passage under the title about Enterovirus, they talk about using a Split-GFP-tagged viral protein. The method involved transducing cells with MLV particles, concentrating them, and creating stable GFP-expressing clones. But how does this relate to tracking spread?\n\nThe second title is about Influenza A viruses with reporter genes. The passage here says that GFP was observable in the lungs of infected mice ex vivo using IVIS for whole-organ imaging. Also, flow cytometry was used to analyze infection progression in antigen-presenting cells. Imaging of murine lungs showed infection starting near large airways and spreading deeper.\n\nSo the question is about tracking the spread. The answer probably combines both imaging techniques. IVIS (In Vivo Imaging System) is used for whole-organ imaging ex vivo. Flow cytometry helps analyze specific cell populations. The spread was tracked by observing where GFP was present over time, starting from the respiratory tract near airways and moving deeper. \n\nThe answer should mention IVIS for whole-organ imaging and flow cytometry for analyzing antigen-presenting cells. Also, the progression from initial infection sites to deeper lung areas. Need to make sure to reference both methods and the observation of GFP in those contexts.\n</think>\n\nThe spread of GFP-expressing virus-infected cells was tracked using **whole-organ imaging of murine lungs ex vivo** (via IVIS) and **flow cytometry analysis of antigen-presenting cells**. Imaging revealed that infection began in the respiratory tract near large conducting airways and progressed to deeper lung regions over time. Additionally, the percentage of GFP+ cells (e.g., dendritic cells, macrophages, and neutrophils) was quantified at 48 hours post-infection to monitor viral dissemination.",
      "retrieved_chunks": [
        "One color channel was imaged, such that images produced show GFP-expressing cells in white and non-GFP-expressing cells in black .",
        "The authors found that using a 10 6 PFU intranasal inoculation, 10% of dendritic cells were observed to express GFP and 2%-3% of macrophages and neutrophils were also GFP+ at 48 h post-infection .",
        "Title: Illuminating the Sites of Enterovirus Replication in Living Cells by Using a Split-GFP-Tagged Viral Protein\nPassage: transduction, the MLV particles were 5 to 10 times concentrated using a 100-kDa concentrator .",
        "For the generation of single-cell clones stably expressing GFP, BGM and HeLa cells were transduced and grown in the presence of puromycin to generate pools of GFP-expressing cells, which were subsequently used to prepare single-cell clones by limiting dilution.",
        "Although the approach to adoptively transfer fluorescent cells of interest into donor mice for functional imaging studies is fast and flexible,\n\nTitle: Replication-Competent Influenza A Viruses Expressing Reporter Genes\nPassage: lungs. Not only was GFP observable in the lungs of infected mice ex vivo using IVIS for whole-organ imaging, but could also be observed using flow cytometry to analyze the infection progression in antigen presenting cells . Imaging of murine lungs showed that infection starts in the respiratory tract in areas close to large conducting airways and later spreads to deeper sections of the lungs ."
      ],
      "computed_relevance": 0.42857142857142855,
      "computed_utilization": 0.8571428571428571,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.21052631578947367,
      "gt_utilization": 0.21052631578947367,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 9,
      "dataset_id": "1261",
      "question": "What's the recommended procedure to disinfect at CT scanner after a COVID-19 exposure?",
      "ground_truth_answer": "The recommended procedure to disinfect a CT scanner after a COVID-19 exposure involves sterilization procedures, noncontaminated CT disinfection procedures, and immediate disinfection of the imaging equipment after the examination.",
      "generated_response": "<think>\nOkay, let's see. The user is asking about the recommended procedure to disinfect a CT scanner after a COVID-19 exposure. The context provided has several passages with similar titles and mentions of CT disinfection procedures.\n\nFirst, I need to parse the context. The titles all mention \"The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\" and the passages talk about noncontaminated CT disinfection procedures after suspected cases, fever-CT disinfection after examination, and preparing to disinfect imaging equipment immediately after the exam.\n\nThe key points here are that after examining a suspected COVID-19 case, the CT equipment needs to be disinfected. The passages mention \"immediately after the examination\" and \"sterilization procedures.\" The term \"noncontaminated CT disinfection procedures\" might be a bit confusing, but since it's after a suspected case, maybe they mean that even though the patient is suspected, the CT is disinfected regardless. \n\nThe answer should probably include steps like immediate disinfection after the exam, using specific sterilization procedures. The context doesn't go into detailed steps, but the main idea is that the equipment is disinfected right after the examination. So the answer would be that the recommended procedure is to disinfect the CT scanner immediately after the examination using the established sterilization protocols.\n</think>\n\nThe recommended procedure to disinfect a CT scanner after a COVID-19 exposure involves **immediately disinfecting the imaging equipment following the examination** using established sterilization protocols. This includes adhering to noncontaminated CT disinfection procedures specifically outlined for suspected or confirmed COVID-19 cases to prevent cross-contamination. The process emphasizes prompt action post-examination to ensure safety and hygiene standards are maintained.",
      "retrieved_chunks": [
        "Title: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: Noncontaminated CT disinfection procedures after suspected COVID-19 case examination\n\nTitle: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: Fever-CT disinfection procedures after examination\n\nTitle: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: fever-CTs) after these sterilization procedures. Title: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: equipment and prepares to disinfect the imaging equipment immediately after the examination."
      ],
      "computed_relevance": 1.0,
      "computed_utilization": 1.0,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.5,
      "gt_utilization": 0.5,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    }
  ],
  "skipped_samples": []
}